Fig. 1From: N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancerFlow chart of the development and validation of an N6-methylandenosine-related lncRNA-based prognostic signature for CESCBack to article page